Last news
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis

...

Accruent Sets New Standard in Workplace Space Optimization with Launch of Accruent Space Intelligence™

Accruent Sets New Standard in Workplace Space Optimization with Launch of Accruent Space Intelligence™

...

Marex Opens New Zealand Office

Marex Opens New Zealand Office

...

Acronis True Image Returns: Reintroducing Acronis' Trusted Home and Office Cyber Protection Solution

Acronis True Image Returns: Reintroducing Acronis' Trusted Home and Office Cyber Protection Solution

...

MGA Entertainment and Zapf Creation AG Complete Merger Forming MGA Zapf Creation GmbH

MGA Entertainment and Zapf Creation AG Complete Merger Forming MGA Zapf Creation GmbH

...

Bedford Metals Identifies Key Uranium Markers at Close Lake Uranium Project

Bedford Metals Identifies Key Uranium Markers at Close Lake Uranium Project

...

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

...

LS Retail and FreedomPay partner to deliver unified payments worldwide

LS Retail and FreedomPay partner to deliver unified payments worldwide

...

1 ... 349 350 351 352 353 354 355 356 357 ... 940
menu
menu